Vertex Pharmaceuticals
VRTX
#175
Rank
C$161.33 B
Marketcap
C$629.25
Share price
-0.41%
Change (1 day)
-2.42%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total debt

Total debt on the balance sheet as of September 2025 : C$2.53 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total debt is C$2.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Vertex Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$2.51 B134.14%
2023-12-31C$1.07 B-12.17%
2022-12-31C$1.22 B-0.98%
2021-12-31C$1.23 B3.76%
2020-12-31C$1.18 B37.5%
2019-12-31C$0.86 B8.11%
2018-12-31C$0.79 B4.84%
2017-12-31C$0.76 B-32.52%
2016-12-31C$1.12 B-1.42%
2015-12-31C$1.14 B19.72%
2014-12-31C$0.95 B77.53%
2013-12-31C$0.53 B-22.19%
2012-12-31C$0.69 B49.42%
2011-12-31C$0.46 B-13.6%
2010-12-31C$0.53 B231.62%
2009-12-31C$0.16 B-53.7%
2008-12-31C$0.34 B1652.32%
2007-12-31C$19.94 M-86.15%
2006-12-31C$0.14 B-31.28%
2005-12-31C$0.20 B-47.89%
2004-12-31C$0.40 B-6.98%
2003-12-31C$0.43 B-16.54%
2002-12-31C$0.51 B-0.7%
2001-12-31C$0.52 B-3.86%
2000-12-31C$0.54 B5232%
1999-12-31C$10.18 M-32.43%
1998-12-31C$15.06 M25.54%
1997-12-31C$12 M3.09%
1996-12-31C$11.64 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
C$34.45 B 1,259.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$94.96 B 3,646.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$57.15 B 2,154.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$70.51 B 2,681.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$63.26 B 2,395.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C$80.19 M-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA